MX2017014196A - Deteccion de factores de virulencia microbiana bucal. - Google Patents

Deteccion de factores de virulencia microbiana bucal.

Info

Publication number
MX2017014196A
MX2017014196A MX2017014196A MX2017014196A MX2017014196A MX 2017014196 A MX2017014196 A MX 2017014196A MX 2017014196 A MX2017014196 A MX 2017014196A MX 2017014196 A MX2017014196 A MX 2017014196A MX 2017014196 A MX2017014196 A MX 2017014196A
Authority
MX
Mexico
Prior art keywords
detection
virulence factors
biological sample
oral microbial
microbial virulence
Prior art date
Application number
MX2017014196A
Other languages
English (en)
Inventor
Christian Haught John
Klukowska Malgorzata
Xie Sancai
Ashok KHAMBE Deepa
James White Donald
Glenn Huggins Thomas
Sue Tansky Cheryl
Thomas Circello Benjamin
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2017014196A publication Critical patent/MX2017014196A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/579—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving limulus lysate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Métodos para detectar y cuantificar toxinas presentes en la cavidad bucal. Los métodos pueden incluir proporcionar una muestra biológica, proporcionar células reporteras que expresan uno o más receptores tipo Toll, exponer las células a la muestra biológica, medir el valor EC50 del lipopolisacárido en la activación de un receptor tipo Toll, cuantificar el lipopolisacárido en la muestra biológica.
MX2017014196A 2015-05-06 2016-05-06 Deteccion de factores de virulencia microbiana bucal. MX2017014196A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562157671P 2015-05-06 2015-05-06
US201562157659P 2015-05-06 2015-05-06
US201662309110P 2016-03-16 2016-03-16
PCT/US2016/031349 WO2016179560A1 (en) 2015-05-06 2016-05-06 Detection of oral microbial virulence factors

Publications (1)

Publication Number Publication Date
MX2017014196A true MX2017014196A (es) 2018-03-01

Family

ID=56024418

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017014198A MX2017014198A (es) 2015-05-06 2016-05-06 Desintoxicacion de los factores de virulencia microbiana en la cavidad oral.
MX2017014196A MX2017014196A (es) 2015-05-06 2016-05-06 Deteccion de factores de virulencia microbiana bucal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017014198A MX2017014198A (es) 2015-05-06 2016-05-06 Desintoxicacion de los factores de virulencia microbiana en la cavidad oral.

Country Status (8)

Country Link
US (3) US10156566B2 (es)
EP (2) EP3292215A1 (es)
CN (2) CN107636464B (es)
AU (2) AU2016258194B2 (es)
BR (2) BR112017023750A2 (es)
CA (2) CA2983629A1 (es)
MX (2) MX2017014198A (es)
WO (2) WO2016179561A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017014198A (es) 2015-05-06 2018-06-28 Procter & Gamble Desintoxicacion de los factores de virulencia microbiana en la cavidad oral.
US9964472B2 (en) 2016-06-29 2018-05-08 The Procter & Gamble Company Methods for sampling gingival metabolites
CN107189986B (zh) * 2017-07-25 2020-08-11 南京大学 一种基于内质网应激的报告基因细胞株构建方法及其应用
CN111077307B (zh) * 2018-10-21 2022-08-23 厦门鲎试剂生物科技股份有限公司 一种用革兰氏阴性细菌感染快速检测脓毒病的新方法
EP4018196A1 (en) * 2020-04-02 2022-06-29 Colgate-Palmolive Company Compositions for and methods of neutralizing lipopolysaccharide toxicity and methods of identifying the same
US20230400459A1 (en) * 2022-06-09 2023-12-14 Hero Scientific Ltd. Gargle specimen sampling
CN115368430B (zh) * 2022-09-02 2024-02-02 北京化工大学 一种雷公藤红素金属络合物的制备方法和应用
WO2024102226A1 (en) * 2022-10-14 2024-05-16 Evelo Biosciences, Inc. Methods for assaying drug substances and drug products by using cell lines with nf-kb- inducible reporter genes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175089A (en) 1988-07-15 1992-12-29 The Trustees Of Columbia University In The City Of New York Method for monitoring periodontal disease by monitoring endotoxins and inflammatory agents
CA2323630A1 (en) 1989-02-14 1990-08-15 Invitron Corporation Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
ATE355380T1 (de) * 1993-04-02 2006-03-15 Rigel Pharmaceuticals Inc Methode zur selektiven inaktivierung der viralen replication
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
US20040258630A1 (en) * 2003-06-23 2004-12-23 Boyd Thomas J. Antiplaque breath freshening consumable film
US8414293B2 (en) * 2005-06-28 2013-04-09 Colgate-Palmolive Company Carrier strip for application to oral surfaces and related methods
BRPI0613515A2 (pt) 2005-07-11 2011-01-11 Cbio Ltd imunomodulação induzida por chaperonina 10
PL1971865T3 (pl) 2006-01-10 2014-02-28 Colgate Palmolive Co Sposoby modulowania powierzchniowych receptorów komórek w celu zapobiegania zapaleniu lub jego zmniejszania
US8147807B2 (en) * 2006-07-20 2012-04-03 National University Corporation Okayama University Oral composition for dental purposes
CN105213247A (zh) * 2006-09-29 2016-01-06 宝洁公司 包含凝胶网络的口腔组合物
AU2008238445B2 (en) * 2007-04-13 2012-02-02 V-Biotek Holding Aps Extract of Trigonella foenum-graecum
US20120019735A1 (en) 2009-03-25 2012-01-26 Koninklijke Philips Electronics N.V. Liquid crystal cell manufacture
AU2011207441A1 (en) * 2010-01-22 2012-08-09 The Trustees Of The University Of Pennsylvania Methods of treating or preventing periodontitis and diseases associated with periodontitis
GB2481267B (en) * 2010-06-15 2016-04-20 Univ Leicester Assay for determining the risk of a toll-like receptor containing foodstuff for causing systemic inflammation in vivo
BR112015014966A2 (pt) 2012-12-20 2017-07-11 Colgate Palmolive Co composição de cuidado oral contendo líquidos iônicos
MX2017014198A (es) 2015-05-06 2018-06-28 Procter & Gamble Desintoxicacion de los factores de virulencia microbiana en la cavidad oral.

Also Published As

Publication number Publication date
WO2016179560A1 (en) 2016-11-10
US20160327557A1 (en) 2016-11-10
AU2016258194A1 (en) 2017-11-30
CN107636464B (zh) 2020-08-11
US9970934B2 (en) 2018-05-15
EP3292215A1 (en) 2018-03-14
AU2016258194B2 (en) 2019-01-03
CN107636464A (zh) 2018-01-26
CA2983625C (en) 2020-11-24
AU2016258195A1 (en) 2017-11-30
CN107567587B (zh) 2020-10-16
WO2016179561A1 (en) 2016-11-10
BR112017023726A2 (pt) 2018-07-31
US10267797B2 (en) 2019-04-23
CA2983625A1 (en) 2016-11-10
AU2016258195B2 (en) 2019-07-04
EP3292216A1 (en) 2018-03-14
US20180231546A1 (en) 2018-08-16
MX2017014198A (es) 2018-06-28
US20170119643A1 (en) 2017-05-04
CA2983629A1 (en) 2016-11-10
US10156566B2 (en) 2018-12-18
BR112017023750A2 (pt) 2018-07-31
CN107567587A (zh) 2018-01-09

Similar Documents

Publication Publication Date Title
MX2017014196A (es) Deteccion de factores de virulencia microbiana bucal.
CL2017001940A1 (es) Dispositivo de medición de la calidad del suelo
MX2023008585A (es) Biodetectores para analisis quimico o biologico y metodos para fabricar los mismos.
GB2556004A (en) Markers of stroke and stroke severity
BR112016007106A2 (pt) dispositivo e método de teste de gravidez melhorado
CR20190574A (es) Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos
MX2017015011A (es) Ensayo a base de celulas para detectar homodimeros anti-cd3.
MA52952A (fr) Méthode de détection permettant la détection d'un analyte dans un échantillon
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
GB2474146A (en) Methods of determining the health status of an individual
EP2759259A3 (en) Apparatus and method for measuring stress based on a behavior of a user
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
DE502008003362D1 (de) Trollverlustes über einen muskel
EP4273551A3 (en) Multiplexed total antibody and antibody-conjugated drug quantification assay
MX2017010569A (es) Dispositivo, plataforma y ensayo para evaluacion de celulas.
GB201014837D0 (en) Biomarker signatures and uses thereof
AU2011285694A8 (en) Detection of degradation products of canine NT-proBNP
EP3521826A4 (en) METHOD, COMPOSITION AND CHIP FOR DETECTING AN ANALYSIS OBJECT IN A BLOOD SAMPLE
EP3737492A4 (en) ELECTROCHEMICAL ANALYSIS DEVICE FOR REAGENT-FREE DETECTION
EP2937421A3 (en) Biomarker for predicting effect of an anti-C-met antibody
BR112019006862A2 (pt) dispositivo de análise e método para testagem de uma amostra

Legal Events

Date Code Title Description
FG Grant or registration